290 related articles for article (PubMed ID: 26410072)
21. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
[TBL] [Abstract][Full Text] [Related]
22. Novel variants in genes related to vesicle-mediated-transport modify Parkinson's disease risk.
Goldstein O; Gana-Weisz M; Banfi S; Nigro V; Bar-Shira A; Thaler A; Gurevich T; Mirelman A; Giladi N; Alcalay RN; Orr-Urtreger A
Mol Genet Metab; 2023 Jun; 139(2):107608. PubMed ID: 37201419
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.
Mutez E; Nkiliza A; Belarbi K; de Broucker A; Vanbesien-Mailliot C; Bleuse S; Duflot A; Comptdaer T; Semaille P; Blervaque R; Hot D; Leprêtre F; Figeac M; Destée A; Chartier-Harlin MC
Neurobiol Dis; 2014 Mar; 63():165-70. PubMed ID: 24269915
[TBL] [Abstract][Full Text] [Related]
24. Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.
Gan-Or Z; Bar-Shira A; Gurevich T; Giladi N; Orr-Urtreger A
Neurogenetics; 2011 Nov; 12(4):325-32. PubMed ID: 21837367
[TBL] [Abstract][Full Text] [Related]
25. Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
Pchelina S; Emelyanov A; Baydakova G; Andoskin P; Senkevich K; Nikolaev M; Miliukhina I; Yakimovskii A; Timofeeva A; Fedotova E; Abramycheva N; Usenko T; Kulabukhova D; Lavrinova A; Kopytova A; Garaeva L; Nuzhnyi E; Illarioshkin S; Zakharova E
Neurosci Lett; 2017 Jan; 636():70-76. PubMed ID: 27780739
[TBL] [Abstract][Full Text] [Related]
26. LRRK2, GBA and SMPD1 Founder Mutations and Parkinson's Disease in Ashkenazi Jews.
Dagan E; Schlesinger I; Kurolap A; Ayoub M; Nassar M; Peretz-Aharon J; Gershoni-Baruch R
Dement Geriatr Cogn Disord; 2016; 42(1-2):1-6. PubMed ID: 27449028
[TBL] [Abstract][Full Text] [Related]
27. Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease.
Giladi N; Mirelman A; Thaler A; Bar-Shira A; Gurevich T; Orr-Urtreger A
J Neurol Sci; 2011 Nov; 310(1-2):17-20. PubMed ID: 21704337
[TBL] [Abstract][Full Text] [Related]
28. Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.
Infante J; Prieto C; Sierra M; Sánchez-Juan P; González-Aramburu I; Sánchez-Quintana C; Berciano J; Combarros O; Sainz J
Neurobiol Aging; 2015 Feb; 36(2):1105-9. PubMed ID: 25475535
[TBL] [Abstract][Full Text] [Related]
29. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk.
Gan-Or Z; Bar-Shira A; Dahary D; Mirelman A; Kedmi M; Gurevich T; Giladi N; Orr-Urtreger A
Arch Neurol; 2012 Jan; 69(1):105-10. PubMed ID: 22232350
[TBL] [Abstract][Full Text] [Related]
30. Genetics of Parkinson's disease--state of the art, 2013.
Bonifati V
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S23-8. PubMed ID: 24262182
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson's disease.
Riboldi GM; Vialle RA; Navarro E; Udine E; de Paiva Lopes K; Humphrey J; Allan A; Parks M; Henderson B; Astudillo K; Argyrou C; Zhuang M; Sikder T; Oriol Narcis J; Kumar SD; Janssen W; Sowa A; Comi GP; Di Fonzo A; Crary JF; Frucht SJ; Raj T
Mol Neurodegener; 2022 Aug; 17(1):52. PubMed ID: 35978378
[TBL] [Abstract][Full Text] [Related]
32. The genetic landscape of Parkinson's disease.
Lunati A; Lesage S; Brice A
Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
[TBL] [Abstract][Full Text] [Related]
33. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.
Ruskey JA; Greenbaum L; Roncière L; Alam A; Spiegelman D; Liong C; Levy OA; Waters C; Fahn S; Marder KS; Chung W; Yahalom G; Israeli-Korn S; Livneh V; Fay-Karmon T; Alcalay RN; Hassin-Baer S; Gan-Or Z
Eur J Med Genet; 2019 Jan; 62(1):65-69. PubMed ID: 29842932
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of severe vs mild GBA mutations on Parkinson disease.
Gan-Or Z; Amshalom I; Kilarski LL; Bar-Shira A; Gana-Weisz M; Mirelman A; Marder K; Bressman S; Giladi N; Orr-Urtreger A
Neurology; 2015 Mar; 84(9):880-7. PubMed ID: 25653295
[TBL] [Abstract][Full Text] [Related]
35. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
[TBL] [Abstract][Full Text] [Related]
36. Presenting symptoms of GBA-related Parkinson's disease.
Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.
Chahine LM; Qiang J; Ashbridge E; Minger J; Yearout D; Horn S; Colcher A; Hurtig HI; Lee VM; Van Deerlin VM; Leverenz JB; Siderowf AD; Trojanowski JQ; Zabetian CP; Chen-Plotkin A
JAMA Neurol; 2013 Jul; 70(7):852-8. PubMed ID: 23699752
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the glucocerebrosidase gene in Parkinson's disease.
Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
[TBL] [Abstract][Full Text] [Related]
39. A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.
den Heijer JM; Cullen VC; Pereira DR; Yavuz Y; de Kam ML; Grievink HW; Moerland M; Leymarie N; Khatri K; Sollomoni I; Spitalny L; Dungeon L; Hilt DC; Justman C; Lansbury P; Groeneveld GJ
Mov Disord; 2023 May; 38(5):783-795. PubMed ID: 36916660
[TBL] [Abstract][Full Text] [Related]
40. Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.
Thaler A; Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Shirvan JC; Cedarbaum JM; Orr-Urtreger A; Regev K; Shenhar-Tsarfaty S; Mirelman A
J Parkinsons Dis; 2021; 11(3):1285-1296. PubMed ID: 33998549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
